Maurizio Puccetti - Concepedia

Author

Maurizio Puccetti

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ORCID

Also Known As

M Puccetti, M. Puccetti, M.P. Puccetti, Maurizio Puccetti

Publications

855

Citations

H-Index

Concepts

All Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico Ospedale "Santa Maria delle Croci" di Ravenna Ospedale G.B. Morgagni - L.Pierantoni ASL Roma

About

Maurizio Puccetti is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	271
2	Health Sciences	2	2	26
3	Engineering	1	1	28
4	Public Health	1	1	38
5	Biostatistics	1	1	38

Maurizio Puccetti

Publications

735

Citations

H-Index

Page 1

	Year	Citations
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis Sara Bravaccini, Maurizio Puccetti, Martine Bocchini, Scientific Reports	2018	178
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy Paola Ulivi, Elisa Chiadini, Claudio Dazzi, Clinical Lung Cancer Clinical-pathological CharacteristicsMedicinePathologyBronchial NeoplasmCancer Genetics	2015	89
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations D. Amadori, Patrizia Serra, Sara Bravaccini, Breast Cancer Research and Treatment Breast OncologyCancer EpidemiologyMedicineEpidemiology Of CancerBiological Features	2014	38
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, BMC Cancer	2018	36
Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection? Paola Ulivi, Angelo Delmonte, Elisa Chiadini, International Journal of Molecular Sciences GeneticsPathologyGene Mutation AnalysisGuide Patient SelectionTyrosine Kinase Inhibitors	2014	30
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer Samanta Salvi, Chiara Molinari, Flavia Foca, OncoTargets and Therapy Surgical OncologyPathologyMir17hg AmplificationCancer BiologyTumor Biology	2016	29
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology Sara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, Oncotarget	2016	29
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, Translational Oncology Androgen ReceptorBreast OncologyEngineeringBetween Primary TumorAr Expression	2018	28
<i>ALK</i> translocation detection in non‐small cell lung cancer cytological samples obtained by TBNA or EBUS‐TBNA Sara Bravaccini, Maria Maddalena Tumedei, Paola Ulivi, Cytopathology	2015	23
Benefit from anthracyclines in relation to biological profiles in early breast cancer Andrea Rocca, Sara Bravaccini, Emanuela Scarpi, Breast Cancer Research and Treatment Breast OncologyEarly Breast CancerMedicineImmunologyBiological Profiles	2013	20

Page 1